|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PERSPECTIVES IN PHARMACOLOGY
Department of Pharmacology, Cardiovascular Biology Center, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Most G protein-coupled receptors (GPCRs) are reversibly activated upon ligand binding. However, activation of protease-activated G protein-coupled receptors (PARs) occurs through an irreversible proteolytic event that results in the generation of a tethered ligand that cannot diffuse away. This unusual mode of PAR activation raises important questions regarding the mechanisms responsible for termination of receptor signaling. There are currently four members of the PAR family. Thrombin activates PAR1, PAR3, and PAR4, whereas multiple trypsin-like serine proteases activate PAR2. The regulation of signaling by PAR1 has been extensively studied, whereas considerably less is known about the other PARs. It has been demonstrated that rapid termination of PAR1 signaling is critical in determining the magnitude and kinetics of the cellular protease response. Therefore, elucidating the molecular mechanisms involved in the regulation of PAR signaling is essential to fully understand protease-mediated responses. Recent findings indicate that novel mechanisms contribute to PAR1 desensitization, internalization, and down-regulation. This review focuses on the intracellular mechanisms that regulate PAR signaling and the recent progress in developing inhibitors of PAR signaling.
Address correspondence to: JoAnn Trejo, Ph.D., University of North Carolina at Chapel Hill, Department of Pharmacology, 1106 Mary Ellen Jones Bldg., CB #7365, Chapel Hill, NC 27599-7365. E-mail: joann_trejo{at}med.unc.edu
This article has been cited by other articles:
![]() |
L. Seminario-Vidal, S. Kreda, L. Jones, W. O'Neal, J. Trejo, R. C. Boucher, and E. R. Lazarowski Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling Pathways J. Biol. Chem., July 31, 2009; 284(31): 20638 - 20648. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kai, K. Hirano, Y. Maeda, J. Nishimura, T. Sasaki, and H. Kanaide Prevention of the Hypercontractile Response to Thrombin by Proteinase-Activated Receptor-1 Antagonist in Subarachnoid Hemorrhage Stroke, December 1, 2007; 38(12): 3259 - 3265. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Jahan, J Fujimoto, S. M. Alam, E Sato, H Sakaguchi, and T Tamaya Role of protease activated receptor-2 in tumor advancement of ovarian cancers Ann. Onc., September 1, 2007; 18(9): 1506 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mandal, U. R. Pendurthi, and L. V. M. Rao Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling Blood, July 1, 2007; 110(1): 161 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Berg, A. M. Patwardhan, T. A. Sanchez, Y. M. Silva, K. M. Hargreaves, and W. P. Clarke Rapid Modulation of {micro}-Opioid Receptor Signaling in Primary Sensory Neurons J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 839 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ayoub, D. Maurel, V. Binet, M. Fink, L. Prezeau, H. Ansanay, and J.-P. Pin Real-Time Analysis of Agonist-Induced Activation of Protease-Activated Receptor 1/G{alpha}i1 Protein Complex Measured by Bioluminescence Resonance Energy Transfer in Living Cells Mol. Pharmacol., May 1, 2007; 71(5): 1329 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hains, M. R. Wing, S. Maddileti, D. P. Siderovski, and T. K. Harden G{alpha}12/13- and Rho-Dependent Activation of Phospholipase C-{epsilon} by Lysophosphatidic Acid and Thrombin Receptors Mol. Pharmacol., June 1, 2006; 69(6): 2068 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Cheema, C. E. Ward, and S. K. Fisher Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 755 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yufu, K. Hirano, D. Bi, M. Hirano, J. Nishimura, Y. Iwamoto, and H. Kanaide Rac1 Regulation of Surface Expression of Protease-Activated Receptor-1 and Responsiveness to Thrombin in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1506 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stalheim, Y. Ding, A. Gullapalli, M. M. Paing, B. L. Wolfe, D. R. Morris, and J. Trejo Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking Mol. Pharmacol., January 1, 2005; 67(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heydorn, B. P. Sondergaard, B. Ersboll, B. Holst, F. C. Nielsen, C. R. Haft, J. Whistler, and T. W. Schwartz A Library of 7TM Receptor C-terminal Tails: INTERACTIONS WITH THE PROPOSED POST-ENDOCYTIC SORTING PROTEINS ERM-BINDING PHOSPHOPROTEIN 50 (EBP50), N-ETHYLMALEIMIDE-SENSITIVE FACTOR (NSF), SORTING NEXIN 1 (SNX1), AND G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN (GASP) J. Biol. Chem., December 24, 2004; 279(52): 54291 - 54303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Debaigt, H. Hirling, P. Steiner, J.-P. Vincent, and J. Mazella Crucial Role of Neuron-enriched Endosomal Protein of 21 kDa in Sorting between Degradation and Recycling of Internalized G-protein-coupled Receptors J. Biol. Chem., August 20, 2004; 279(34): 35687 - 35691. [Abstract] [Full Text] [PDF] |
||||